Prognose

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Microneedles for Drug Delivery Patent Landscape Report and Forecast 2024-2032, Featuring Minnesota Mining and Manufacturing, BD and Co, Zosano Pharma, Raphas, Nano, and Pass Technologies
Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Microneedles for Drug Delivery Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.» Mehr auf globenewswire.com
Why Zosano Pharma Shares Are Getting Hammered Today
Zosano Pharma Corp (NASDAQ: ZSAN) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11. Zosano says the company continues to operate its business as a "debtor-in-possession" under the jurisdiction of the.» Mehr auf benzinga.com
Zosano Pharma Reports First Quarter 2022 Financial Results
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results and statements has been retroactively adjusted to give effect to our April 11, 2022 1-for-35 reverse stock split.» Mehr auf globenewswire.com

Im letzten Jahr hatte Zosano Pharma Aktie einen Umsatz von 690,33k€ und ein Nettoeinkommen von −26,48 Mio€